All news

Longitude Capital sells 500,000 MANE shares for $75.2 million

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

Longitude Capital Partners V, a major shareholder in Veradermics (NYSE:MANE), sold 500,000 shares for $75.2 million, reducing its stake by over 21%. Despite this, analysts maintain a "Moderate Buy" rating for Veradermics, with an average price target of

Read original source

MANE company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.